13 June 2025
13 June 2025
The future of US immunisation is up in the air as outspoken critics of vaccines populate an integral recommendation committee.
The transaction will see BioNTech assimilate its former rival in the Covid-19 vaccine arena.
The label expansion for Moderna鈥檚 jab arrives at a juncture in America鈥檚 changing vaccine regulatory landscape.
The decision is based on data from a Phase III, single-arm, prospective multicentre trial.
The health secretary addressed NHS employees a day after the 拢29bn NHS funding was announced.
GlobalData estimates that vutrisiran鈥檚 entrance into the ATTR-wt market will change the treatment paradigm.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
